Allopurinol Tablets 100mg — Class II drug recall D-0173-2023
Terminated recall by Preferred Pharmaceuticals, Inc., reported 2023-02-01, distributed in IN. Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece
| Recall number | D-0173-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Preferred Pharmaceuticals, Inc., Anaheim, CA, United States |
| Recall initiated | 2023-01-16 |
| Classified | 2023-01-23 |
| Reported by FDA | 2023-02-01 |
| Terminated | 2023-04-14 |
| Distributed | IN |
| Quantity | 9 bottles |
| Reason classes | packaging |
| NDC | 68788-7383-09 |
| Lot numbers | K3022Q |
| Expiration dates | 2025-03-31 |
Product
Allopurinol Tablets 100mg, USP, 90-count bottles, Rx Only, 90, Mfg: Accord Healthcare, Inc; Durham, NC, PREFERRED Pharmaceuticals, Inc., The Physician's Solution, Prod#: 68788-7383-09.
Reason for recall
Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack towards the edge of the tablet.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0173-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.